Momentum Reports

MOMENTUM REPORTS — TETRA BIO PHARMA

Highlights:

  • Canadian-based pioneer, innovator and first to market in cannabis-based pharmaceuticals
  • Global medical marijuana market is estimated to reach US$55.8 billion by 2025
  • Tetra Bio-Pharma is the first and only bio-pharma company in North-America focused on cannabinoid (CBD) clinical stage pain relief products
  • Tetra is the only bio-pharma company currently running a double-blind Phase 1 study with organically-grown cannabis
  • Positive outcome from trials will result in for North-American Drug Identification Numbers (DIN), thus qualifying prescriptions for insurance coverage.
  • Strategic partnership with Aphria Inc. announced in November 2016 and solidified in April 2017

Get in touch with us to discuss this opportunity further

TOP
Message Us
Loading...